Joleen J.H. Traets - Concepedia

Author

Joleen J.H. Traets

Also Known As

J Traets, J.J.H. Traets, Joleen J H Traets, Joleen J. H. Traets, Joleen J. Traets, Joleen J.H. Traets, Joleen JH Traets, Joleen Traets

107

Publications

765

Citations

H-Index

Concepts

All Affiliations

Oncode Institute The Netherlands Cancer Institute Leiden University Medical Center VIB-KU Leuven Center for Cancer Biology University Medical Center Utrecht

About

Joleen J.H. Traets is an author at Oncode Institute specializing in medicine, cancer research, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	37
2	Health Sciences	1	1	21
3	Cell Biology	1	1	16
4	Immunology	1	1	16
5	Radiation Medicine	1	1	21

Joleen J.H. Traets

Publications

746

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma Joris L. Vos, Joris B.W. Elbers, Oscar Krijgsman, Nature Communications	2021	317
A pan-cancer analysis of the microbiome in metastatic cancer Thomas Battaglia, Iris Mimpen, Joleen J.H. Traets, Cell	2024	162
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling Georgi Apriamashvili, David W. Vredevoogd, Oscar Krijgsman, Nature Communications	2022	50
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial Iris Nederlof, Olga I. Isaeva, Manon De Graaf, Nature Medicine	2024	44
Dual Immune Checkpoint Blockade Induces Analogous Alterations in the Dysfunctional CD8+ T-cell and Activated Treg Compartment Anne M. van der Leun, Joleen J.H. Traets, Joris L. Vos, Cancer Discovery	2023	32
An adverse tumor-protective effect of IDO1 inhibition Juliana C.N. Kenski, Xinyao Huang, David W. Vredevoogd, Cell Reports Medicine	2023	29
High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer Evert van den Broek, Maurits Dijkstra, Oscar Krijgsman, PLoS ONE	2015	28
Towards organ preservation and cure via 2 infusions of immunotherapy only, in patients normally undergoing extensive and mutilating curative surgery for cutaneous squamous cell carcinoma: An investigator-initiated randomized phase II trial—The MATISSE trial. Charlotte L. Zuur, Sabine E. Breukers, Mercedes Machuca-Ostos, Journal of Clinical Oncology Surgical OncologyCancer ManagementAdvanced Cutaneous SccSurgeryDermatology	2023	21
TSC2 regulates tumor susceptibility to TRAIL‐mediated T‐cell killing by orchestrating mTOR signaling Chun‐Pu Lin, Joleen J.H. Traets, David W. Vredevoogd, The EMBO Journal Tumor BiologyTumor SusceptibilityCancer ImmunosurveillanceSignal TransductionImmunology	2023	16
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness Chun‐Pu Lin, Pierre Lévy, Astrid Alflen, Cancer Cell	2024	15

Page 1